🟢 Oncolytics Biotech is trading 5% up today as XBI rises 2.75%

Oncolytics Biotech is trading at $0.88, up 5.02%, with biotech-sector momentum the likeliest driver.

• No fresh company-specific announcement was identified for September 2, 2026.
• August 18 FDA alignment on a potential registrational colorectal-cancer pathway and July Fast Track designation for pelareorep remain supportive, but neither directly explains today’s move.
• XBI rose 2.75% during regular trading.